Sg3 Management, LLC Amarin Corp Plcuk Call Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $54,720 - $71,616	19,200 Added 231.33%	27,500 $90,000
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $49,842 - $76,050	-11,700 Reduced 58.5%	8,300 $36,000
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $163,475 - $286,000	-32,500 Reduced 61.9%	20,000 $124,000
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $50,500 - $66,375	12,500 Added 31.25%	52,500 $257,000
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $215,100 - $371,700	-45,000 Reduced 52.94%	40,000 $277,000
Q1 2020 May 12, 2020	BUY	$4.0 - $21.53 $340,000 - $1.83 Million	85,000 New	85,000 $340,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.